The Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market is expected to witness market growth at a CAGR of 25% during the forecast period of 2022 to 2028.
Tranthyretin amyloidosis (ATTR) is a rare, progressive and severe disease. Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of transthyretin amyloidosis (ATTR) that affects the heart and causes restrictive cardiomyopathy and progressive heart failure. It is a rare, life-threatening condition that is usually underdiagnosed. The increasing incidence of transthyretin amyloid cardiomyopathy (ATTR-CM) among the aging population is expected to drive the growth of the transthyretin amyloid cardiomyopathy (ATTR-CM) market. For example, according to an article published by the World Heart Federation in August 2019, wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) is the more common type and usually affects men after the age of 60. Hereditary transthyretin amyloidosis (hATTR) occurs in people in their 50s and 60s.
(Get 15% Discount on Buying this Report)
A full report of Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market is available at: https://orionmarketreports.com/transthyretin-amyloid-cardiomyopathy-attr-cm-treatment-market/102890/
Market Segments
By Type
- Hereditary Transthyretin Amyloidosis (hATTR)
- Wild Type Transthyretin Amyloidosis (wtATTR)
By Drug Type
- Transthyretin Stabilizers
- Nonsteroidal anti-inflammatory drugs (NSAID)
- RNAi therapy
Key Players
- Pfizer Inc
- GlaxoSmithKline Plc.
- Eidos Therapeutics
- Ionis Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals
- Prothena Corporation plc
- Intellia Therapeutics, Inc.
- Corino Therapeutics, Inc.
Scope of the Report
The research study analyzes the global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Report
1. What was the Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment market.
- The market share of the global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
